Seoul, South Korea

You Hyun Kang

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Eutilex Co., Ltd.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: You Hyun Kang. Retrieved from https://idiyas.com/inventor/you-hyun-kang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: You Hyun Kang: Innovator in Cancer Immunotherapy

Introduction

You Hyun Kang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer immunotherapy, particularly through his innovative research and development of pharmaceutical compositions aimed at treating cancer.

Latest Patents

One of his notable patents is related to a pharmaceutical composition for preventing or treating cancer. This invention involves cancer antigen-specific cytotoxic T cells, which are crucial for targeting and eliminating cancer cells. The composition comprises about 7×10 cells/mL or more, with approximately 90% or more of these cells being CD8+ T cells. This patent highlights his commitment to advancing cancer treatment methodologies.

Career Highlights

You Hyun Kang is associated with Eutilex Co., Ltd., a company dedicated to developing innovative therapies for cancer treatment. His work at Eutilex has positioned him as a key player in the field of immunotherapy, where he continues to explore new avenues for effective cancer treatment.

Collaborations

He has collaborated with notable colleagues, including Byoung S Kwon and Young Ho Kim. These partnerships have fostered a collaborative environment that enhances the research and development of groundbreaking cancer therapies.

Conclusion

You Hyun Kang's contributions to cancer immunotherapy through his innovative patents and collaborations underscore his importance in the field. His work continues to inspire advancements in cancer treatment, offering hope for improved patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…